These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25379735)

  • 1. Assessment of Digoxin-Specific Fab Fragment Dosages in Digoxin Poisoning.
    Nordt SP; Clark RF; Machado C; Cantrell FL
    Am J Ther; 2016; 23(1):e63-7. PubMed ID: 25379735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-Specific Antibody Fragment Dosing: A Case Series.
    Chhabra N; Valento M; Bryant SM; Aks SE
    Am J Ther; 2016; 23(6):e1597-e1601. PubMed ID: 26057142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.
    Lapostolle F; Borron SW; Verdier C; Taboulet P; Guerrier G; Adnet F; Clemessy JL; Bismuth C; Baud FJ
    Crit Care Med; 2008 Nov; 36(11):3014-8. PubMed ID: 18824911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4).
    Chan BS; Isbister GK; Page CB; Isoardi KZ; Chiew AL; Kirby KA; Buckley NA
    Clin Toxicol (Phila); 2019 Jul; 57(7):638-643. PubMed ID: 30585517
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
    Ujhelyi MR; Colucci RD; Cummings DM; Green PJ; Robert S; Vlasses PH; Zarowitz BJ
    DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study.
    Bilbault P; Oubaassine R; Rahmani H; Lavaux T; Castelain V; Sauder P; Schneider F
    Eur J Emerg Med; 2009 Jun; 16(3):145-9. PubMed ID: 19262393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-specific antibody fragments: how much and when?
    Bateman DN
    Toxicol Rev; 2004; 23(3):135-43. PubMed ID: 15862081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopharmacologic treatment of 9 digitalis poisonings in children with sheep antidigoxin Fab].
    Smolarz A; Abshagen U
    Monatsschr Kinderheilkd; 1985 Sep; 133(9):682-7. PubMed ID: 4058431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].
    Weller P; Peters U; Dickmanns HA; Hespe TH; Adam M; Allolio B; Smolarz A; Grabensee B
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1437-40. PubMed ID: 6884234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].
    Smolarz A; Roesch E; Lenz H; Neubert P; Abshagen U
    Z Kardiol; 1984 Feb; 73(2):113-9. PubMed ID: 6719984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.
    Wenger TL; Butler VP; Haber E; Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):118A-123A. PubMed ID: 3886748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
    Smith TW; Butler VP; Haber E; Fozzard H; Marcus FI; Bremner WF; Schulman IC; Phillips A
    N Engl J Med; 1982 Nov; 307(22):1357-62. PubMed ID: 6752715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.
    Smith TW; Haber E; Yeatman L; Butler VP
    N Engl J Med; 1976 Apr; 294(15):797-800. PubMed ID: 943040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe digoxin intoxication in a 15-year-old girl treated with Fab antidigoxin].
    Gómez Barrado JJ; García Rubira JC; Turégano Albarrán S; García Martínez JT; Trujillo Berraquero F; Molano Casimiro F
    Rev Esp Cardiol; 1996 Apr; 49(4):311-3. PubMed ID: 8650409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.